-
1
-
-
77955444881
-
Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy
-
Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010 ; 106: 360-368
-
(2010)
Am J Cardiol
, vol.106
, pp. 360-368
-
-
Turer, A.T.1
Hill, J.A.2
-
2
-
-
79955527497
-
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog
-
Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 1960 ; 70: 68-78
-
(1960)
Arch Pathol
, vol.70
, pp. 68-78
-
-
Jennings, R.B.1
Sommers, H.M.2
Smyth, G.A.3
Flack, H.A.4
Linn, H.5
-
3
-
-
0022970945
-
Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
-
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 ; 74: 1124-1136
-
(1986)
Circulation
, vol.74
, pp. 1124-1136
-
-
Murry, C.E.1
Jennings, R.B.2
Reimer, K.A.3
-
4
-
-
0032510660
-
Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop
-
Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation ; 1998 ; 1998. 1848.
-
Circulation
-
-
Kloner, R.A.1
Bolli, R.2
Marban, E.3
Reinlib, L.4
Braunwald, E.5
-
5
-
-
0025810599
-
The cell biology of acute myocardial ischemia
-
Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med. 1991 ; 42: 225-246
-
(1991)
Annu Rev Med
, vol.42
, pp. 225-246
-
-
Jennings, R.B.1
Reimer, K.A.2
-
6
-
-
0035909985
-
Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 2
-
Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation. 2001 ; 104: 3158-3167
-
(2001)
Circulation
, vol.104
, pp. 3158-3167
-
-
Kloner, R.A.1
Jennings, R.B.2
-
7
-
-
0035846605
-
Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 1
-
Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation. 2001 ; 104: 2981-2989
-
(2001)
Circulation
, vol.104
, pp. 2981-2989
-
-
Kloner, R.A.1
Jennings, R.B.2
-
8
-
-
34548746306
-
Myocardial reperfusion injury
-
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007 ; 357: 1121-1135
-
(2007)
N Engl J Med
, vol.357
, pp. 1121-1135
-
-
Yellon, D.M.1
Hausenloy, D.J.2
-
9
-
-
79957937929
-
Targeting fatty acid and carbohydrate oxidation: A novel therapeutic intervention in the ischemic and failing heart
-
Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation: a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 2011 ; 1813: 1333-1350
-
(2011)
Biochim Biophys Acta
, vol.1813
, pp. 1333-1350
-
-
Jaswal, J.S.1
Keung, W.2
Wang, W.3
Ussher, J.R.4
Lopaschuk, G.D.5
-
10
-
-
50049086740
-
AMP-activated protein kinase control of energy metabolism in the ischemic heart
-
Lopaschuk GD. AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int J Obes (Lond). 2008 ; 32 (suppl 4). S29 - S35
-
(2008)
Int J Obes (Lond)
, vol.32
, Issue.SUPPL. 4
-
-
Lopaschuk, G.D.1
-
11
-
-
33846447778
-
Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease
-
Lopaschuk GD, Stanley WC. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease. Cardiovasc Drugs Ther. 2006 ; 20: 433-439
-
(2006)
Cardiovasc Drugs Ther
, vol.20
, pp. 433-439
-
-
Lopaschuk, G.D.1
Stanley, W.C.2
-
12
-
-
77950348533
-
Inhibition of mitochondrial permeability transition pore opening: The Holy Grail of cardioprotection
-
Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol. 2010 ; 105: 151-154
-
(2010)
Basic Res Cardiol
, vol.105
, pp. 151-154
-
-
Heusch, G.1
Boengler, K.2
Schulz, R.3
-
13
-
-
68649090703
-
The role of the mitochondrial permeability transition pore in heart disease
-
Halestrap AP, Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta. 2009 ; 1787: 1402-1415
-
(2009)
Biochim Biophys Acta
, vol.1787
, pp. 1402-1415
-
-
Halestrap, A.P.1
Pasdois, P.2
-
14
-
-
77956605222
-
Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease
-
Cadenas S, Aragones J, Landazuri MO. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc Res. 2010 ; 88: 219-228
-
(2010)
Cardiovasc Res
, vol.88
, pp. 219-228
-
-
Cadenas, S.1
Aragones, J.2
Landazuri, M.O.3
-
15
-
-
0032805207
-
Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function
-
Cain BS, Meldrum DR, Dinarello CA, et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med. 1999 ; 27: 1309-1318
-
(1999)
Crit Care Med
, vol.27
, pp. 1309-1318
-
-
Cain, B.S.1
Meldrum, D.R.2
Dinarello, C.A.3
-
16
-
-
78650971588
-
TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure
-
Kleinbongard P, Schulz R, Heusch G. TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev. 2011 ; 16: 49-69
-
(2011)
Heart Fail Rev
, vol.16
, pp. 49-69
-
-
Kleinbongard, P.1
Schulz, R.2
Heusch, G.3
-
17
-
-
79951679204
-
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury
-
Kawaguchi M, Takahashi M, Hata T, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation. 2011 ; 123: 594-604
-
(2011)
Circulation
, vol.123
, pp. 594-604
-
-
Kawaguchi, M.1
Takahashi, M.2
Hata, T.3
-
19
-
-
80052180144
-
Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure
-
Fragasso G, Salerno A, Lattuada G, et al. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure. Heart. 2011 ; 97: 1495-1500
-
(2011)
Heart
, vol.97
, pp. 1495-1500
-
-
Fragasso, G.1
Salerno, A.2
Lattuada, G.3
-
21
-
-
79551469280
-
Trimetazidine: A meta-analysis of randomised controlled trials in heart failure
-
Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart. 2011 ; 97: 278-286
-
(2011)
Heart
, vol.97
, pp. 278-286
-
-
Gao, D.1
Ning, N.2
Niu, X.3
Hao, G.4
Meng, Z.5
-
22
-
-
79551494641
-
Metabolic modulation in heart failure: High time for a definitive clinical trial
-
Ashrafian H, Neubauer S. Metabolic modulation in heart failure: high time for a definitive clinical trial. Heart. 2011 ; 97: 267-268
-
(2011)
Heart
, vol.97
, pp. 267-268
-
-
Ashrafian, H.1
Neubauer, S.2
-
23
-
-
70350560556
-
Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart
-
Ko HJ, Zhang Z, Jung DY, et al. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes. 2009 ; 58: 2536-2546
-
(2009)
Diabetes
, vol.58
, pp. 2536-2546
-
-
Ko, H.J.1
Zhang, Z.2
Jung, D.Y.3
-
24
-
-
0036153778
-
Warm up phenomenon and preconditioning in clinical practice
-
Tomai F. Warm up phenomenon and preconditioning in clinical practice. Heart. 2002 ; 87: 99-100
-
(2002)
Heart
, vol.87
, pp. 99-100
-
-
Tomai, F.1
-
25
-
-
56449100005
-
Remote ischemic preconditioning: A novel protective method from ischemia reperfusion injury-A review
-
Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury-a review. J Surg Res. 2008 ; 150: 304-330
-
(2008)
J Surg Res
, vol.150
, pp. 304-330
-
-
Tapuria, N.1
Kumar, Y.2
Habib, M.M.3
Abu Amara, M.4
Seifalian, A.M.5
Davidson, B.R.6
-
27
-
-
79953775326
-
Playing with cardiac "redox switches": The "hNO way" to modulate cardiac function
-
Tocchetti CG, Stanley BA, Murray CI, et al. Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function. Antioxid Redox Signal. 2011 ; 14: 1687-1698
-
(2011)
Antioxid Redox Signal
, vol.14
, pp. 1687-1698
-
-
Tocchetti, C.G.1
Stanley, B.A.2
Murray, C.I.3
-
28
-
-
51249093667
-
Myocardial protection by nitrite: Evidence that this reperfusion therapeutic will not be lost in translation
-
Sinha SS, Shiva S, Gladwin MT. Myocardial protection by nitrite: evidence that this reperfusion therapeutic will not be lost in translation. Trends Cardiovasc Med. 2008 ; 18: 163-172
-
(2008)
Trends Cardiovasc Med
, vol.18
, pp. 163-172
-
-
Sinha, S.S.1
Shiva, S.2
Gladwin, M.T.3
-
29
-
-
0037623908
-
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning
-
Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003 ; 285: H579 - H588
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.285
-
-
Zhao, Z.Q.1
Corvera, J.S.2
Halkos, M.E.3
-
30
-
-
40749130846
-
Long-term benefit of postconditioning
-
Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation. 2008 ; 117: 1037-1044
-
(2008)
Circulation
, vol.117
, pp. 1037-1044
-
-
Thibault, H.1
Piot, C.2
Staat, P.3
-
31
-
-
77954910444
-
Postconditioning the human heart in percutaneous coronary intervention
-
Xue F, Yang X, Zhang B, et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol. 2010 ; 33: 439-444
-
(2010)
Clin Cardiol
, vol.33
, pp. 439-444
-
-
Xue, F.1
Yang, X.2
Zhang, B.3
-
32
-
-
34249026375
-
Postconditioning the human heart with adenosine in heart valve replacement surgery
-
Jin ZX, Zhou JJ, Xin M, et al. Postconditioning the human heart with adenosine in heart valve replacement surgery. Ann Thorac Surg. 2007 ; 83: 2066-2072
-
(2007)
Ann Thorac Surg
, vol.83
, pp. 2066-2072
-
-
Jin, Z.X.1
Zhou, J.J.2
Xin, M.3
-
33
-
-
34147093239
-
"Postconditioning" the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection
-
Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. "Postconditioning" the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol. 2007 ; 102: 274-278
-
(2007)
Basic Res Cardiol
, vol.102
, pp. 274-278
-
-
Darling, C.E.1
Solari, P.B.2
Smith, C.S.3
Furman, M.I.4
Przyklenk, K.5
-
34
-
-
26944445765
-
Postconditioning the human heart
-
Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation. 2005 ; 112: 2143-2148
-
(2005)
Circulation
, vol.112
, pp. 2143-2148
-
-
Staat, P.1
Rioufol, G.2
Piot, C.3
-
35
-
-
74049107874
-
Post-conditioning for cardioprotection during reperfusion therapy: Too good to be true?
-
Prasad A. Post-conditioning for cardioprotection during reperfusion therapy: too good to be true?. JACC Cardiovasc Interv. 2010 ; 3: 56-57
-
(2010)
JACC Cardiovasc Interv
, vol.3
, pp. 56-57
-
-
Prasad, A.1
-
36
-
-
78650168192
-
ST-segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance
-
Lonborg J, Holmvang L, Kelbaek H, et al. ST-segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. Am Heart J. 2010 ; 160: 1085-1091
-
(2010)
Am Heart J
, vol.160
, pp. 1085-1091
-
-
Lonborg, J.1
Holmvang, L.2
Kelbaek, H.3
-
37
-
-
81255195550
-
Ischemia and reperfusion: From mechanism to translation
-
Eltzschig HK, Eckle T. Ischemia and reperfusion: from mechanism to translation. Nat Med. 2011 ; 17: 1391-1401
-
(2011)
Nat Med
, vol.17
, pp. 1391-1401
-
-
Eltzschig, H.K.1
Eckle, T.2
-
38
-
-
79952039647
-
Toll-like receptor signaling during myocardial ischemia
-
Eckle T, Eltzschig HK. Toll-like receptor signaling during myocardial ischemia. Anesthesiology. 2011 ; 114: 490-492
-
(2011)
Anesthesiology
, vol.114
, pp. 490-492
-
-
Eckle, T.1
Eltzschig, H.K.2
-
39
-
-
80051721082
-
Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model
-
Wang RP, Yao Q, Xiao YB, et al. Toll-like receptor 4/nuclear factor-kappa B pathway is involved in myocardial injury in a rat chronic stress model. Stress. 2011 ; 14: 567-575
-
(2011)
Stress
, vol.14
, pp. 567-575
-
-
Wang, R.P.1
Yao, Q.2
Xiao, Y.B.3
-
40
-
-
67650102620
-
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: Mediating KC and MCP-1 expression induced by extracellular HSC70
-
Ao L, Zou N, Cleveland JC, Fullerton DA, Meng X. Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol. 2009 ; 297: H21 - H28
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.297
-
-
Ao, L.1
Zou, N.2
Cleveland, J.C.3
Fullerton, D.A.4
Meng, X.5
-
41
-
-
58149500135
-
Toll-like receptor signaling: A critical modulator of cell survival and ischemic injury in the heart
-
Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol. 2009 ; 296: H1 - H12
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
-
-
Chao, W.1
-
42
-
-
79952535561
-
Endotoxin release in cardiac surgery with cardiopulmonary bypass: Pathophysiology and possible therapeutic strategies-an update
-
Kats S, Schonberger JP, Brands R, Seinen W, van Oeveren W. Endotoxin release in cardiac surgery with cardiopulmonary bypass: pathophysiology and possible therapeutic strategies-an update. Eur J Cardiothorac Surg. 2011 ; 39: 451-458
-
(2011)
Eur J Cardiothorac Surg
, vol.39
, pp. 451-458
-
-
Kats, S.1
Schonberger, J.P.2
Brands, R.3
Seinen, W.4
Van Oeveren, W.5
-
43
-
-
0037010009
-
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: The results of the HALT-MI study
-
Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002 ; 40: 1199-204
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 1199-1204
-
-
Faxon, D.P.1
Gibbons, R.J.2
Chronos, N.A.3
Gurbel, P.A.4
Sheehan, F.5
-
44
-
-
70349658872
-
Adenosine: An old drug newly discovered
-
Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology. 2009 ; 111: 904-915
-
(2009)
Anesthesiology
, vol.111
, pp. 904-915
-
-
Eltzschig, H.K.1
-
45
-
-
79251625729
-
Targeting hypoxia-induced Inflammation
-
Eltzschig HK. Targeting hypoxia-induced Inflammation. Anesthesiology. 2011 ; 114: 239-242
-
(2011)
Anesthesiology
, vol.114
, pp. 239-242
-
-
Eltzschig, H.K.1
-
47
-
-
11244261365
-
Vascular ischaemia and reperfusion injury
-
Eltzschig HK, Collard CD. Vascular ischaemia and reperfusion injury. Br Med Bull. 2004 ; 70: 71-86
-
(2004)
Br Med Bull
, vol.70
, pp. 71-86
-
-
Eltzschig, H.K.1
Collard, C.D.2
-
48
-
-
51049101334
-
Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases
-
Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008 ; 7: 759-770
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 759-770
-
-
Hasko, G.1
Linden, J.2
Cronstein, B.3
Pacher, P.4
-
49
-
-
34247343418
-
Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors
-
Eckle T, Krahn T, Grenz A, et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation. 2007 ; 115: 1581-1590
-
(2007)
Circulation
, vol.115
, pp. 1581-1590
-
-
Eckle, T.1
Krahn, T.2
Grenz, A.3
-
50
-
-
33646031836
-
Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade
-
Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006 ; 70: 308-314
-
(2006)
Cardiovasc Res
, vol.70
, pp. 308-314
-
-
Philipp, S.1
Yang, X.M.2
Cui, L.3
Davis, A.M.4
Downey, J.M.5
Cohen, M.V.6
-
51
-
-
0031024750
-
Glucose metabolism in the ischemic heart
-
Lopaschuk GD, Stanley WC. Glucose metabolism in the ischemic heart. Circulation. 1997 ; 95: 313-315
-
(1997)
Circulation
, vol.95
, pp. 313-315
-
-
Lopaschuk, G.D.1
Stanley, W.C.2
-
52
-
-
0024385671
-
Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir
-
Lopaschuk GD, McNeil GF, McVeigh JJ. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol Cell Biochem. 1989 ; 88: 175-179
-
(1989)
Mol Cell Biochem
, vol.88
, pp. 175-179
-
-
Lopaschuk, G.D.1
McNeil, G.F.2
McVeigh, J.J.3
-
53
-
-
2942512039
-
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: A double-blind placebo-controlled study
-
Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol. 2003 ; 2: 16
-
(2003)
Cardiovasc Diabetol
, vol.2
, pp. 16
-
-
Rosano, G.M.1
Vitale, C.2
Sposato, B.3
Mercuro, G.4
Fini, M.5
-
54
-
-
55249098908
-
The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease
-
Grabczewska Z, Bialoszynski T, Szymanski P, et al. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease. Cardiol J. 2008 ; 15: 344-350
-
(2008)
Cardiol J
, vol.15
, pp. 344-350
-
-
Grabczewska, Z.1
Bialoszynski, T.2
Szymanski, P.3
-
55
-
-
4944222848
-
Efficacy and safety of a metabolic modulator drug in chronic stable angina: Review of evidence from clinical trials
-
Chaitman BR. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials. J Cardiovasc Pharmacol Ther. 2004 ; 9 (suppl 1). S47 - S64
-
(2004)
J Cardiovasc Pharmacol Ther
, vol.9
, Issue.SUPPL. 1
-
-
Chaitman, B.R.1
-
56
-
-
20844432056
-
Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction
-
Türel B, Gemici K, Baran I, et al. Effects of glucose-insulin- potassium solution added to reperfusion treatment in acute myocardial infarction. Anadolu Kardiyol Derg. 2005 ; 5: 90-94
-
(2005)
Anadolu Kardiyol Derg
, vol.5
, pp. 90-94
-
-
Türel, B.1
Gemici, K.2
Baran, I.3
-
57
-
-
43449089513
-
Glucose-insulin-potassium for acute myocardial infarction: Continuing controversy over cardioprotection
-
Kloner RA, Nesto RW. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation. 2008 ; 117: 2523-2533
-
(2008)
Circulation
, vol.117
, pp. 2523-2533
-
-
Kloner, R.A.1
Nesto, R.W.2
-
58
-
-
18844445117
-
A challenge to the metabolic approach to myocardial ischaemia
-
Apstein CS, Opie LH. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J. 2005 ; 26: 956-959
-
(2005)
Eur Heart J
, vol.26
, pp. 956-959
-
-
Apstein, C.S.1
Opie, L.H.2
-
59
-
-
17744399714
-
Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart
-
Wang P, Lloyd SG, Chatham JC. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation. 2005 ; 111: 2066-2072
-
(2005)
Circulation
, vol.111
, pp. 2066-2072
-
-
Wang, P.1
Lloyd, S.G.2
Chatham, J.C.3
-
60
-
-
65649101870
-
The metabolic treatment of patients with coronary artery disease: Effects on quality of life and effort angina
-
Cesar LA, Gowdak LH, Mansur AP. The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina. Curr Pharm Des. 2009 ; 15: 841-849
-
(2009)
Curr Pharm des
, vol.15
, pp. 841-849
-
-
Cesar, L.A.1
Gowdak, L.H.2
Mansur, A.P.3
-
61
-
-
77949343027
-
The cardiomyocyte circadian clock: Emerging roles in health and disease
-
Durgan DJ, Young ME. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res. 2010 ; 106: 647-658
-
(2010)
Circ Res
, vol.106
, pp. 647-658
-
-
Durgan, D.J.1
Young, M.E.2
-
62
-
-
42549165229
-
Linking the cardiomyocyte circadian clock to myocardial metabolism
-
Durgan DJ, Young ME. Linking the cardiomyocyte circadian clock to myocardial metabolism. Cardiovasc Drugs Ther. 2008 ; 22: 115-124
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, pp. 115-124
-
-
Durgan, D.J.1
Young, M.E.2
-
63
-
-
79953666149
-
Evidence suggesting that the cardiomyocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice
-
Durgan DJ, Tsai JY, Grenett MH, et al. Evidence suggesting that the cardiomyocyte circadian clock modulates responsiveness of the heart to hypertrophic stimuli in mice. Chronobiol Int. 2011 ; 28: 187-203
-
(2011)
Chronobiol Int
, vol.28
, pp. 187-203
-
-
Durgan, D.J.1
Tsai, J.Y.2
Grenett, M.H.3
-
64
-
-
33747662966
-
The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids
-
Durgan DJ, Trexler NA, Egbejimi O, et al. The circadian clock within the cardiomyocyte is essential for responsiveness of the heart to fatty acids. J Biol Chem. 2006 ; 281: 24254-24269
-
(2006)
J Biol Chem
, vol.281
, pp. 24254-24269
-
-
Durgan, D.J.1
Trexler, N.A.2
Egbejimi, O.3
-
65
-
-
77649094910
-
Short communication: Ischemia/reperfusion tolerance is time-of-day-dependent: Mediation by the cardiomyocyte circadian clock
-
Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, et al. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res. 2010 ; 106: 546-550
-
(2010)
Circ Res
, vol.106
, pp. 546-550
-
-
Durgan, D.J.1
Pulinilkunnil, T.2
Villegas-Montoya, C.3
-
67
-
-
39149108483
-
Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression
-
Bray MS, Shaw CA, Moore MW, et al. Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol. 2008 ; 294: H1036 - H1047
-
(2008)
Am J Physiol Heart Circ Physiol
, vol.294
-
-
Bray, M.S.1
Shaw, C.A.2
Moore, M.W.3
-
68
-
-
21344470923
-
Circadian rhythms from multiple oscillators: Lessons from diverse organisms
-
Bell-Pedersen D, Cassone VM, Earnest DJ, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet. 2005 ; 6: 544-556
-
(2005)
Nat Rev Genet
, vol.6
, pp. 544-556
-
-
Bell-Pedersen, D.1
Cassone, V.M.2
Earnest, D.J.3
-
69
-
-
1442333357
-
Central and peripheral circadian oscillators in Drosophila
-
Hardin PE, Krishnan B, Houl JH, et al. Central and peripheral circadian oscillators in Drosophila. Novartis Found Symp. 2003 ; 253: 140-150
-
(2003)
Novartis Found Symp
, vol.253
, pp. 140-150
-
-
Hardin, P.E.1
Krishnan, B.2
Houl, J.H.3
-
70
-
-
33751250489
-
Essential and expendable features of the circadian timekeeping mechanism
-
Hardin PE. Essential and expendable features of the circadian timekeeping mechanism. Curr Opin Neurobiol. 2006 ; 16: 686-692
-
(2006)
Curr Opin Neurobiol
, vol.16
, pp. 686-692
-
-
Hardin, P.E.1
-
71
-
-
24044444531
-
The circadian timekeeping system of Drosophila
-
Hardin PE. The circadian timekeeping system of Drosophila. Curr Biol. 2005 ; 15: R714 - R722
-
(2005)
Curr Biol
, vol.15
-
-
Hardin, P.E.1
-
72
-
-
78649687209
-
Circadian integration of metabolism and energetics
-
Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010 ; 330: 1349-1354
-
(2010)
Science
, vol.330
, pp. 1349-1354
-
-
Bass, J.1
Takahashi, J.S.2
-
73
-
-
77954848215
-
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes
-
Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010 ; 466: 627-631
-
(2010)
Nature
, vol.466
, pp. 627-631
-
-
Marcheva, B.1
Ramsey, K.M.2
Buhr, E.D.3
-
74
-
-
79959843192
-
Genomic convergence among ERRalpha, PROX1, and BMAL1 in the control of metabolic clock outputs
-
Dufour CR, Levasseur MP, Pham NH, et al. Genomic convergence among ERRalpha, PROX1, and BMAL1 in the control of metabolic clock outputs. PLoS Genet. 2011 ; 7: e1002143
-
(2011)
PLoS Genet
, vol.7
, pp. 1002143
-
-
Dufour, C.R.1
Levasseur, M.P.2
Pham, N.H.3
|